Journal issues > Issue 5, September > Highlights in gastrointestinal cancers

Highlights in gastrointestinal cancers

SUMMARY

The 2024 ASCO meeting will be remembered for the presentation of the TRANSMET trial, a study in carefully selected patients with definitely unresectable liver metastases, showing that liver transplantation is feasible and leads to better survival. We also learned that thermal ablation is a safe alternative for surgery for small liver metastases in patients with colorectal cancer. The ESOPAC trial is another important study answering a long-standing question on the optimal perioperative treatment in patients with adenocarcinoma of the oesophagus or GEJ junction.

(Belg J Med Oncol 2024;18(5):201–5)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top